Resistant hypertension revisited

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Neurogenic hypertension revisited.

Sixteen years ago I reviewed (Dickinson, 1965) the evidence that essential hypertension was neurogenically initiated and suggested that its primary cause was a rise in the minimal resistance of the arteries supplying the brain stem. At that time very few investigators supported a neurogenic hypothesis andthose that did believed that the neurogenic stimulus was psychological, rather than organic...

متن کامل

Resistant Hypertension

High blood pressure (BP) is the leading risk factor for premature death and disability-adjusted life years in the world. The development of a large pharmaceutical base from which to manage patients with hypertension in addition to many patient years of clinical trial experience have made it possible to successfully manage many of these patients. Nonetheless, many questions remain, particularly ...

متن کامل

Resistant hypertension.

Recent clinical trials suggest that resistant hypertension is increasingly common. In the majority of patients, uncontrolled hypertension is due to persistent elevation of the systolic blood pressure. Older age and obesity are associated with poor blood pressure control. Other contributing factors include severity of the underlying hypertension and renal insufficiency. Poor patient adherence is...

متن کامل

Resistant Hypertension

High blood pressure (BP) is the leading risk factor for premature death and disability-adjusted life years in the world. The development of a large pharmaceutical base from which to manage patients with hypertension in addition to many patient years of clinical trial experience have made it possible to successfully manage many of these patients. Nonetheless, many questions remain, particularly ...

متن کامل

Resistant Hypertension

High blood pressure (BP) is the leading risk factor for premature death and disability-adjusted life years in the world. The development of a large pharmaceutical base from which to manage patients with hypertension in addition to many patient years of clinical trial experience have made it possible to successfully manage many of these patients. Nonetheless, many questions remain, particularly ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: American Journal of Hypertension

سال: 2002

ISSN: 0895-7061

DOI: 10.1016/s0895-7061(02)02335-x